Inflammaging in Dermatology: A New Frontier for Research

5Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

As humans age, our ability to manage certain types of inflammation is reduced. As a result, we experience chronic, low-grade inflammation, which has been termed “inflammaging”. This type of low-level inflammation is driven by a progressive increase in proinflammatory systemic cytokines over time. Inflammaging is thought to contribute to many age-related chronic diseases including cardiovascular disease, diabetes, Alzheimer’s disease, and even certain cancers. Recent studies suggest that the human microbiome may play a critical role in inflammaging. As the largest organ of the body and home to a significant portion of the human microbiome, the skin may play a unique role in inflammaging. In this review article, we present common dermatological diseases through the lens of inflammaging, look at how our skin may play a role in reducing inflammaging, and highlight the need for further focused research in this area.

Cite

CITATION STYLE

APA

Haque, A., & Woolery-Lloyd, H. (2021). Inflammaging in Dermatology: A New Frontier for Research. Journal of Drugs in Dermatology, 20(2), 144–149. https://doi.org/10.36849/JDD.5481

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free